AALR3 Stock Overview
Provides diagnostic medicine services in Brazil. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Alliança Saúde e Participações S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$13.95 |
| 52 Week High | R$17.32 |
| 52 Week Low | R$6.15 |
| Beta | 1.04 |
| 11 Month Change | 14.34% |
| 3 Month Change | -3.79% |
| 1 Year Change | 30.74% |
| 33 Year Change | -18.42% |
| 5 Year Change | -28.35% |
| Change since IPO | -27.34% |
Recent News & Updates
Alliança Saúde e Participações S.A. (BVMF:AALR3) Stock Rockets 36% As Investors Are Less Pessimistic Than Expected
Aug 25
Optimistic Investors Push Alliança Saúde e Participações S.A. (BVMF:AALR3) Shares Up 60% But Growth Is Lacking
Jul 11What Alliança Saúde e Participações S.A.'s (BVMF:AALR3) 26% Share Price Gain Is Not Telling You
Apr 17Recent updates
Alliança Saúde e Participações S.A. (BVMF:AALR3) Stock Rockets 36% As Investors Are Less Pessimistic Than Expected
Aug 25Optimistic Investors Push Alliança Saúde e Participações S.A. (BVMF:AALR3) Shares Up 60% But Growth Is Lacking
Jul 11What Alliança Saúde e Participações S.A.'s (BVMF:AALR3) 26% Share Price Gain Is Not Telling You
Apr 17Centro de Imagem Diagnósticos (BVMF:AALR3) Will Be Hoping To Turn Its Returns On Capital Around
Aug 17Why Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) Could Be Worth Watching
Jul 08Is Centro de Imagem Diagnósticos (BVMF:AALR3) Using Too Much Debt?
May 28What Is Centro de Imagem Diagnósticos S.A.'s (BVMF:AALR3) Share Price Doing?
Apr 05Reflecting on Centro de Imagem Diagnósticos' (BVMF:AALR3) Share Price Returns Over The Last Three Years
Mar 10Should You Buy Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) For Its Dividend?
Feb 17What Percentage Of Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) Shares Do Insiders Own?
Jan 27
Would Centro de Imagem Diagnósticos (BVMF:AALR3) Be Better Off With Less Debt?
Jan 06What Does Centro de Imagem Diagnósticos S.A.'s (BVMF:AALR3) Share Price Indicate?
Dec 11Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) Is Yielding 0.8% - But Is It A Buy?
Aug 07Centro de Imagem Diagnósticos S.A.'s (BVMF:AALR3) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Jul 20Is Centro de Imagem Diagnósticos (BVMF:AALR3) Likely To Turn Things Around?
Jul 03Shareholder Returns
| AALR3 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | -6.4% | -1.2% | -0.4% |
| 1Y | 30.7% | -17.2% | -2.2% |
Return vs Industry: AALR3 exceeded the BR Healthcare industry which returned -13.6% over the past year.
Return vs Market: AALR3 exceeded the BR Market which returned -1.6% over the past year.
Price Volatility
| AALR3 volatility | |
|---|---|
| AALR3 Average Weekly Movement | 7.5% |
| Healthcare Industry Average Movement | 6.0% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in BR Market | 8.5% |
| 10% least volatile stocks in BR Market | 2.2% |
Stable Share Price: AALR3's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: AALR3's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of BR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | n/a | Isabella Correa | www.allianca.com |
Alliança Saúde e Participações S.A. provides diagnostic medicine services in Brazil. It offers imaging diagnosis and graphic methods; nuclear medicine cytology; pathological anatomy; human vaccination and immunization; medical activity; and clinical analysis, as well as other auxiliary diagnostic support services. The company also engages in the import of medical and hospital equipment, diagnostic sets, and related items; provision of consultancy, advice, courses, and lectures in the health area; managing chronic diseases; research and development in the area of diagnostic medicine; preparation, editing, publication, and distribution of newspapers, books, magazines, periodicals, and other written communication vehicles intended for scientific dissemination; and granting and administration of business franchises.
Alliança Saúde e Participações S.A. Fundamentals Summary
| AALR3 fundamental statistics | |
|---|---|
| Market cap | R$1.68b |
| Earnings (TTM) | -R$218.43m |
| Revenue (TTM) | R$1.19b |
1.4x
P/S Ratio-7.5x
P/E RatioIs AALR3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AALR3 income statement (TTM) | |
|---|---|
| Revenue | R$1.19b |
| Cost of Revenue | R$834.69m |
| Gross Profit | R$354.27m |
| Other Expenses | R$572.70m |
| Earnings | -R$218.43m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.85 |
| Gross Margin | 29.80% |
| Net Profit Margin | -18.37% |
| Debt/Equity Ratio | 75.1% |
How did AALR3 perform over the long term?
See historical performance and comparison